Fineline Cube

Follow:
14398 Articles
Merck's Keytruda Gains Two Additional EU Indications for Gynecologic Cancer Treatment
CompanyDrug

Merck’s Keytruda Gains Two Additional EU Indications for Gynecologic Cancer Treatment

WuXi AppTec Reports Q3 2024 Revenues of RMB 10.46 Billion Amid Biosecure Act Challenges
Company

WuXi AppTec Reports Q3 2024 Revenues of RMB 10.46 Billion Amid Biosecure Act Challenges

Monte Rosa Therapeutics Strikes Licensing Deal with Novartis for VAV1 Degraders
CompanyDeals

Monte Rosa Therapeutics Strikes Licensing Deal with Novartis for VAV1 Degraders

Jiangsu Hengrui Medicine Advances Clinical Trials for Cancer Therapies with NMPA Clearance
CompanyDrug

Jiangsu Hengrui Pharmaceuticals Advances Clinical Trials for Cancer Therapies with NMPA Clearance

AstraZeneca's Fasenra Approved by EU for Eosinophilic Granulomatosis Treatment
CompanyDrug

AstraZeneca’s Fasenra Approved by EU for Eosinophilic Granulomatosis Treatment

AbbVie Inks $1.4 Billion Deal to Acquire Alzheimer's Drug Developer Aliada Therapeutics
CompanyDrug

AbbVie Inks $1.4 Billion Deal to Acquire Alzheimer’s Drug Developer Aliada Therapeutics

CSPC Pharmaceutical's SYS6020 Receives NMPA Approval for Myasthenia Gravis Clinical Trial
CompanyDrug

CSPC Pharmaceutical’s SYS6020 Receives NMPA Approval for Myasthenia Gravis Clinical Trial

Eli Lilly’s Ebglyss Shows Positive Results in Phase III Study for Atopic Dermatitis Patients Previously Treated with Dupilumab
CompanyDrug

Eli Lilly’s Ebglyss Shows Positive Results in Phase III Study for Atopic Dermatitis Patients Previously Treated with Dupilumab

CANbridge Pharmaceuticals Scales Back US Operations, Focuses on China for R&D and Commercialization
Company

CANbridge Pharmaceuticals Scales Back US Operations, Focuses on China for R&D and Commercialization

Biogen's Felzartamab Demonstrates Promising Results in Phase II Study for IgA Nephropathy
CompanyDrug

Biogen’s Felzartamab Demonstrates Promising Results in Phase II Study for IgA Nephropathy

Humanwell Healthcare Receives NMPA Approval for Chemically Synthesized Semaglutide Clinical Trial
CompanyDrug

Humanwell Healthcare Receives NMPA Approval for Chemically Synthesized Semaglutide Clinical Trial

RiboX Therapeutics' Circular RNA Therapy RXRG001 Gets FDA Green Light for Dry Mouth Clinical Trial
CompanyDrug

RiboX Therapeutics’ Circular RNA Therapy RXRG001 Gets FDA Green Light for Dry Mouth Clinical Trial